• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Valeant's Tender Offer For Allergan - Just 4% Of Shares Tendered In Dismal Failure

Re: Valeant's Tender Offer For Allergan - Just 4% Of Shares Tendered In Dismal Failur

A chief level leadership group usually protects a company after an offer is on the table. A chief level leader doesn't let an activist hedge fund owner buy 10% of a 49B company. Wake up fools, they aren't going anywhere... They scoff at BS rumors - these guys are pros at getting this stuff done, something's gonna give, and so far I haven't been impressed with the team defense. Many people were let go, many more are scared, and the same fools keep singing praise for the leaders, I am just not buying it!
 




Re: Valeant's Tender Offer For Allergan - Just 4% Of Shares Tendered In Dismal Failur

A chief level leadership group usually protects a company after an offer is on the table. A chief level leader doesn't let an activist hedge fund owner buy 10% of a 49B company. Wake up fools, they aren't going anywhere... They scoff at BS rumors - these guys are pros at getting this stuff done, something's gonna give, and so far I haven't been impressed with the team defense. Many people were let go, many more are scared, and the same fools keep singing praise for the leaders, I am just not buying it!

Annnnnd the intern is so sad